Physician · Scientific founder

Dr. Carsten Lekutat

The data that could protect the next patient is created every day in primary care. We just aren't looking.

Portrait of Dr. Carsten Lekutat

01 — Path

A physician who builds.

I am board-certified in family and sports medicine, and I still see patients. I have spent years making medicine public — on television, in books, on stage — not as a second career, but as a craft: taking a dense system and making it clear enough that people can care.

That is also how ideas spread in science and in business. Nobody joins work they cannot understand. Communication is not decoration. It is one of the tools that make it work.

For partners

A founder science can take seriously — and who still moves fast.

For scientists

A physician-scientist who can work with industry — and who still stays precise.

02 — Origin

Founding case

I still see patients. This case is why I also build.

One clinic learned.
The region did not.

A man in his early twenties came to my practice with what looked like an ordinary respiratory infection. Within three days he was in intensive care, on a ventilator, where he stayed for weeks. Only there did they identify the pathogen, and the antibiotic that finally worked.

His parents brought that information back to me. In the weeks that followed I could treat other patients with respiratory infections more precisely — because one patient had brought back information that medicine usually loses.

I should have called every practice nearby. That is not how medicine works. It takes too much time, and it isn't the culture. So I built the system that does.

01 / 03

The warning should come before intensive care.

03 — The blind spot

Official tracking looks at hospitals. Most antibiotics are prescribed in primary care.

The lag

Hospital samples go through labs and into national guidelines months or years later. They tell you what already happened. They don't warn the doctor writing a prescription today.

What's never counted

Most antibiotics are prescribed in primary care, based on symptoms, without a lab test. That information is never recorded. Resistance can spread in the community without ever showing up in the data.

The result that disappears

When the first antibiotic doesn't work, the patient comes back for a stronger one. That first failure is almost never recorded. It leaves with the patient.

Curiosity got me started. Responsibility is why I stay — not just for the patient in the room, but for the community they go home to. The pandemic made it obvious: this is local, and it is worldwide. We take care of each other, or we don't. This is personal to me.

04 — Life Sentinel

Every infection treated without a lab test is a live experiment.

ASCA Intelligence built Life Sentinel as a closed-loop system on the crowd intelligence of primary care, using AI, machine learning, and algorithms.

01

Document

Diagnosis and treatment, captured in the visit. Light enough for real practice.

02

Recommend

Doctors see what still works nearby — not last year’s guideline.

03

Return

The visit is not the last word. What happens after still belongs to the care.

04

Update

The system learns from the alpha patient.

Theseus is an observational study at several sites in Germany. It accompanies the platform and builds the evidence for worldwide approval. The Saxon State Chamber of Physicians supports the work.

05 — Companies

Three companies. One founder.

Europe · Flagship

ASCA Intelligence Ltd.

The European company. The science, under Europe's strict privacy rules. Life Sentinel and Theseus live here. Role: CEO, Scientific Founder.

Delaware · Capital

Incredible Brainforest

The American company. Built for speed, and for working with investors. This is where the work meets capital. Role: CEO.

Singapore · Growth

Vertical Nunchi Pte. Ltd.

The Asian company. The door into growth markets and the hub for Southeast Asia, in one of the most advanced cities of the world. Role: CEO.

06 — Contact

If you want to talk, write.

contact@lekutat.de